NICOLETTE OWENS: Open Payments
NPI 1346914512 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,054 in 101 payments from 25 companies in 2025. Trend: 2023 $1,653 · 2024 $2,332 · 2025 $2,054
Food & beverage: $2,054
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $306 |
| ABBVIE INC. | 16 | $272 |
| Novo Nordisk Inc | 16 | $248 |
| Sumitomo Pharma America, Inc. | 6 | $153 |
| PFIZER INC. | 7 | $141 |
| GlaxoSmithKline, LLC. | 6 | $122 |
| Amgen Inc. | 6 | $97 |
| Aimmune Therapeutics, Inc. | 4 | $85 |
| Eisai Inc. | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $67 |
Products named: BREZTRI, GEMTESA, TRELEGY ELLIPTA, AIRSUPRA, Ozempic, ELIQUIS, LINZESS, VRAYLAR.
Industry payments across AZ — which companies pay providers there.
